Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.
Pyramidal neurons in layer 5 of the cerebral cortex are involved in learning and memory and have complex connections with other neurons through a very large array of dendrites. These dendrites can switch between long term depression and long term potentiation depending on global summation of various inputs. The plasticity of the input into pyramidal neurons makes the neuronal output variable. Many interneurons in the cerebral cortex and distant neurons in other brain regions are involved in providing input to pyramidal neurons. All of these neurons and interneurons have neurotransmitters that act through receptors to provide input to pyramidal neurons. Serotonin is one of the important neurotransmitters involved with pyramidal neurons and has been implicated in psychosis, psychedelic states and what are called sacred dreams. This review will discuss the various chemicals and receptors that are important with pyramidal neurons including opioids, nicotine, scopolamine, psilocybin, LSD, mescaline, ergot alkaloids, salvinorin A, ergine and other compounds that interact with opioid, nicotinic, muscarinic and serotonergic receptors. The natural compounds provide clues to structure activity relationships with the receptors. It has been postulated that each receptor in the body has a natural agonist and antagonist, in addition to the normal neurotransmitters. It is common for natural antagonists and agonists to be peptides. Various possible peptide structures will be proposed for natural antagonists and agonists at each receptor. Natural antagonists and agonists may provide new ways to explore the functions of pyramidal neurons in normal health and pain management.
University of Southern California, School of Pharmacy, Department of Pharmacology and Pharmaceutical Sciences, 1985 Zonal Avenue, Los Angeles, CA 90089-9121, USA. jadams@usc.edu
J D
JD
Adams
D001007:Anxiety / Q000188:drug therapy; D002540:Cerebral Cortex / Q000166:cytology*; D009474:Neurons / Q000187:drug effects*; D018377:Neurotransmitter Agents / Q000737:chemistry / Q000494:pharmacology; D010146:Pain / Q000188:drug therapy; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology; D011978:Receptors, Nicotinic / Q000378:metabolism; D044348:Receptors, Serotonin, 5-HT2 / Q000378:metabolism
D018377:Neurotransmitter Agents; D010455:Peptides; D011978:Receptors, Nicotinic; D044348:Receptors, Serotonin, 5-HT2